Sysmex Co. (OTCMKTS:SSMXY) Sees Large Decline in Short Interest

Sysmex Co. (OTCMKTS:SSMXY) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 66.7% from the February 28th total of 3,000 shares. Based on an average daily trading volume, of 109,300 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Sysmex Stock Performance

Shares of SSMXY traded up $0.28 during mid-day trading on Friday, hitting $19.15. 64,964 shares of the company traded hands, compared to its average volume of 67,634. The stock has a market cap of $12.05 billion, a price-to-earnings ratio of 36.87 and a beta of 0.88. The stock has a 50-day moving average price of $18.61 and a two-hundred day moving average price of $19.10. Sysmex has a 1 year low of $14.38 and a 1 year high of $28.32. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.42 and a current ratio of 3.19.

Sysmex (OTCMKTS:SSMXY) last announced its earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share for the quarter. Equities analysts anticipate that Sysmex will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.